Clinical significance of a second-line chemotherapy regimen with paclitaxel, ifosfamide and nedaplatin for metastatic urothelial carcinoma after failure of cisplatin-based chemotherapy-Reference-Cited by-同舟云学术

Clinical significance of a second-line chemotherapy regimen with paclitaxel, ifosfamide and nedaplatin for metastatic urothelial carcinoma after failure of cisplatin-based chemotherapy

Published:2016-08-01 Issue:8 Volume:46 Page:775-780
ISSN:1465-3621
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Kobayashi Keita¹,Matsuyama Hideyasu¹,Shimizu Kosuke¹,Fujii Nakanori¹,Inoue Ryo¹,Yamamoto Yoshiaki¹,Matsumoto Hiroaki¹,Nagao Kazuhiro¹

Affiliation:

1. Department of Urology, Graduate School of Medicine, Yamaguchi University, Yamaguchi, Japan

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/46/8/775/26649953/hyw071.pdf

Reference36 articles.

1. De novo muscle invasive bladder cancer: is there a change in trend;Vaidya;J Urol,2001

2. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer;Grossman;N Engl J Med,2003

3. Advanced Bladder Cancer Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis;Lancet (London, England),2003

4. Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma;Porten;Cancer,2014

5. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study;Loehrer;J Clin Oncol,1992

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive analysis of scRNA-seq and bulk RNA-seq reveal the characteristics of disulfidptosis and a prognostic signature in BLCA;Aging;2024-03-20

2. Elucidation of Novel Molecular Targets for Therapeutic Strategies in Urothelial Carcinoma: A Literature Review;Frontiers in Oncology;2021-08-05

3. Epidemiology and treatment patterns for locally advanced or metastatic urothelial carcinoma: a systematic literature review and gap analysis;Journal of Managed Care & Specialty Pharmacy;2021-02

4. Pembrolizumab versus chemotherapy in recurrent, advanced urothelial cancer in Japanese patients: a subgroup analysis of the phase 3 KEYNOTE-045 trial;International Journal of Clinical Oncology;2019-11-15

5. Outcome and prognostic factors in metastatic urothelial carcinoma patients receiving second-line chemotherapy: an analysis of real-world clinical practice data in Japan;Japanese Journal of Clinical Oncology;2018-06-25